Common questions about Lacrifluid (FAQ)
Q: Does Lacrifluid contain preservatives?
Official documentation for Carbomer 980 ophthalmic products indicates that some multi-dose formulations contain a preservative, such as Cetrimide. Single-dose versions, however, are commonly available and typically described as being preservative-free. Information about the specific formulation used is detailed on the packaging or in the product information sheet.
Q: What is the expected duration of the lubricating effect from one dose of Lacrifluid?
Regulatory documents describe the product’s use as generally being three to four times daily, or as required (pro re nata or p.r.n.). This use pattern indicates that the product's duration of effect is linked to symptomatic requirement and allows for flexible application based on need.
Q: Are there any serious side effects associated with Lacrifluid that have been reported?
Regulatory documentation (SmPC) classifies known adverse reactions by frequency (e.g., Very Common or Uncommon). The most frequent reaction is described as transient blurred vision, which typically resolves quickly. The documentation categorizes effects primarily as Eye disorders and does not classify specific reactions as serious in the frequency tables.
Q: What should be done if the dropper tip accidentally touches the eye or another surface?
Official regulatory instructions emphasize that the tip of the container should avoid contact with any surface, including the eye, to prevent contamination. If the container is a single-dose unit and contact occurs, the regulatory requirement is that the remaining contents should be discarded immediately after the single use.
Q: What is the difference between Lacrifluid and other popular dry eye drops like [Competitor Brand A]?
Regulatory documents describe this product as containing a high-molecular-weight polymer, Carbomer 980, which functions as a viscosity augmenter. This means the formulation is highly viscous, a property that is officially noted for increasing its retention and stability on the ocular surface.
Q: Is it safe to use Lacrifluid after its expiration date?
The established stability and sterility of the product are guaranteed only until the product’s labeled expiration date. This applies only if the product has been stored correctly, such as below 25 C. Regulatory documents do not provide information regarding the safety or efficacy of the product after this date.
Q: What should a user do if symptoms of dry eye worsen after using Lacrifluid?
Official regulatory labeling advises that if symptoms continue or worsen despite using the product, the patient is recommended to have their condition reviewed by an eye specialist or another healthcare professional.
Q: Does Lacrifluid help with irritation encountered after eye surgery?
Regulatory use statements indicate that the product is intended for the symptomatic relief of dry eye conditions. This includes relief from irritation encountered in various ocular conditions, and some documentation specifically mentions use in the context of conditions after eye surgery.
Q: Why does Lacrifluid come in single-dose units?
Single-dose eye drops are widely available and, according to regulatory-linked product information, they are often manufactured to be preservative-free. This approach is commonly used to provide an alternative for patients who may experience sensitivity or adverse reactions related to preservatives like Cetrimide.
Q: What is the risk of contamination with single-dose units of Lacrifluid?
The risk of contamination for single-dose containers is managed by the regulatory guidance that requires them to be used for only one application and discarded immediately. Because they are often preservative-free, they are not designed to be stored after opening.
Q: What if a user misses a dose of Lacrifluid?
The application regimen is defined in regulatory documents as as required (pro re nata) or up to three to four times daily. This means that application is primarily governed by symptomatic need, rather than adherence to a rigid fixed schedule.
Q: Does Lacrifluid address inflammation or only provide lubrication?
The official therapeutic indication, as stated in regulatory documents, is the substitution of tear fluid in the management of dry eye conditions. This is a physical action focused on ocular lubrication and tear film stabilization; the product is not officially indicated as a primary anti-inflammatory agent.
Q: Are there different strengths or concentrations of Lacrifluid available?
Official labeling for the product describes a specific concentration of Carbomer 980, such as 0.2% w/w, for the product being regulated. While regulatory documents detail the composition of this specific product, they do not generally provide a list of all potential concentrations that may be available in the marketplace.
Q: Do I need to see a doctor before starting to use Lacrifluid?
This product is generally available without a prescription for use in adults. However, regulatory labeling advises consulting a physician, pharmacist, or eye specialist if dry eye symptoms persist, worsen, or continue despite use.
Q: What are the ingredients listed in the single-dose Lacrifluid solution?
Official documentation lists the active ingredient as Carbomer 980, a synthetic polymer. Other components typically include purified water and excipients used to adjust the product's pH level to be compatible with the eye.
Q: Is it safe to drive or operate machinery after using Lacrifluid?
Regulatory labeling advises that due to the transient blurring of vision that may occur upon instillation, it is generally recommended that individuals avoid driving or operating hazardous machinery until normal vision is fully restored.
Q: Can I use Lacrifluid for eye redness, or is it just for dryness?
The official indication is for the symptomatic treatment of dry eye syndrome. Regulatory documents list eye redness in the undesirable effects section as an uncommon reported reaction, meaning it is not an indication for treatment.
Q: Is Lacrifluid available in a multi-dose bottle?
Official packaging documentation lists presentations that include multi-dose containers (such as tubes or bottles). Regulatory instructions indicate that these multi-dose containers should be discarded 28 days after first opening.
Q: What should I do if I accidentally swallow a small amount of Lacrifluid?
Regulatory information indicates that due to the product's high molecular weight and negligible systemic absorption (meaning very little enters the bloodstream), clinically relevant systemic effects from small accidental ingestion are generally not anticipated. All medicines should be stored out of the sight and reach of children.
